AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...

AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April 2025, according to data released by ...

Pharma giant AbbVie has been taken to task by the FDA for running an ad for one of its migraine drugs, featuring tennis star Serena Williams, which the agency says overstates its efficacy.

Stocks recently featured in the blog include: Johnson & Johnson JNJ and AbbVie ABBV. Here are highlights from Tuesday’s Analyst Blog: JNJ vs. ABBV: Which Big Pharma Powerhouse Has the Better ...

AbbVie is poised to grow this year for the first ... Kennedy has floated the idea of banning pharmaceutical companies from placing TV ads in the United States. It sounds scary, but pharmaceutical ...

We recently published a list of the 15 Best Dividend Stocks to Buy for Long-Term Passive Income. In this article, we are ...

AbbVie Inc. ABBV, a biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company's stock traded at ...